Mismatch repair deficiency is rare in bone and soft tissue tumors

INTRODUCTION: There has been an increased demand for mismatch repair (MMR) status testing in sarcoma patients after the success of immune checkpoint inhibition (ICI) in MMR deficient tumors. However, data on MMR deficiency in bone and soft tissue tumors is sparse, rendering it unclear if routine scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Suk Wai, Kostine, Marie, de Miranda, Noel F C C, Schöffski, Patrick, Lee, Che‐Jui, Morreau, Hans, Bovée, Judith V M G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518745/
https://www.ncbi.nlm.nih.gov/pubmed/33825202
http://dx.doi.org/10.1111/his.14377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518745/
https://www.ncbi.nlm.nih.gov/pubmed/33825202
http://dx.doi.org/10.1111/his.14377

Ejemplares similares